State Street Corp Has $36.60 Million Stock Position in Core Laboratories Inc. (NYSE:CLB)

State Street Corp grew its holdings in Core Laboratories Inc. (NYSE:CLB) by 2.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,975,016 shares of the oil and gas company’s stock after purchasing an additional 56,187 shares during the quarter. State Street Corp owned about 4.21% of Core Laboratories worth $36,597,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CLB. Headlands Technologies LLC acquired a new stake in shares of Core Laboratories in the 2nd quarter valued at about $36,000. nVerses Capital LLC bought a new position in shares of Core Laboratories in the third quarter valued at approximately $48,000. GAMMA Investing LLC lifted its stake in Core Laboratories by 33.0% during the 3rd quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company’s stock valued at $109,000 after acquiring an additional 1,460 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Core Laboratories by 11.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 600 shares in the last quarter. Finally, Signaturefd LLC lifted its position in shares of Core Laboratories by 12.8% during the 2nd quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock worth $137,000 after buying an additional 767 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Trading Down 4.4 %

Shares of Core Laboratories stock opened at $16.85 on Friday. The company’s 50-day moving average price is $19.62 and its 200-day moving average price is $19.67. The company has a market cap of $791.11 million, a price-to-earnings ratio of 25.92, a PEG ratio of 1.36 and a beta of 2.35. Core Laboratories Inc. has a 12-month low of $13.82 and a 12-month high of $25.13. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.04. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The company had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. During the same quarter last year, the company earned $0.22 earnings per share. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. On average, equities analysts expect that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Monday, November 4th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s dividend payout ratio is currently 6.15%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CLB. Citigroup decreased their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat.com, Core Laboratories presently has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.